Group 1 - The "Xiehe Innovation Port" project aims to bridge the "last mile" of pharmaceutical innovation and has officially launched in Beijing's Dongcheng District, with a target scale of 4 billion yuan for the results transformation fund [1] - The project is a collaboration between the Chinese Academy of Medical Sciences Peking Union Medical College and Dongcheng District, marking a new phase of collaborative innovation in China's healthcare sector [1][2] - The project will focus on key areas such as innovative drugs, high-end medical devices, and artificial intelligence in healthcare, creating a closed-loop ecosystem from original innovation to industrial implementation [1] Group 2 - The first phase of the results transformation fund is set at 1 billion yuan, targeting investments in cutting-edge fields like gene and cell therapy and high-end medical devices [2] - The fund aims to leverage state-owned capital to attract social capital, providing comprehensive capital and professional service support for the transformation of scientific achievements [2] - The project is expected to cultivate a number of "Xiehe system" high-tech enterprises by 2030, forming a biopharmaceutical industry cluster [1][2]